Skip to content

Japan Approves Pfizer and Moderna’s Omicron Boosters for Use

  • Pfizer advised for 12 and over; Moderna just for those over 18
  • Japan joins US, UK, others in endorsing omicron-tailored shots
Updated on

Pfizer Inc. and Moderna Inc.’s Covid-19 vaccines targeting the omicron variant were approved by Japan’s health ministry late Monday, paving the way for them to be rolled out in the world’s third-largest health-care market. 

The ministry endorsed the shots shortly after an expert panel advised deploying the boosters. Pfizer’s omicron booster can be administered to Japanese aged 12 and over, the panel advised, while Moderna’s should be limited to those 18 and above.